AFFF Lawsuit 2026: Which Cancers Qualify, Who Can Still File & What 3M's $12.5 Billion Settlement Means for You
If you served as a firefighter, worked on a military base, or lived near a contaminated site — and were later diagnosed with kidney or testicular cancer — you may still file an AFFF lawsuit in 2026. Thousands of cases are pending in court and moving toward trial. Here is who qualifies, which diseases count, and what 3M's $12.5 billion deal covers.
Key facts
- All federal AFFF personal-injury cases sit in MDL No. 2873, In re: Aqueous Film-Forming Foams Products Liability Litigation, in the U.S. District Court for the District of South Carolina before Judge Richard Gergel.
- More than 10,000 individual cases are pending across federal courts, most of them consolidated in the MDL.
- In June 2023, 3M agreed to pay up to $12.5 billion over 13 years to settle claims by public water systems — the largest drinking-water settlement in U.S. history.
- In April 2024, the EPA finalized the first federal drinking-water standards for PFAS, with enforceable limits of 4.0 parts per trillion for PFOA and PFOS.
- In 2023, the International Agency for Research on Cancer classified PFOA as carcinogenic to humans (Group 1) and PFOS as possibly carcinogenic (Group 2B).
What AFFF is and why it is everywhere
AFFF — aqueous film-forming foam — is a firefighting foam designed to smother fuel fires. Since the 1970s it has been the standard suppressant at military bases, airports, naval facilities, refineries, and civilian fire departments. Its power comes from PFAS (per- and polyfluoroalkyl substances), synthetic chemicals nicknamed "forever chemicals" because they barely break down in the environment or the human body.
Sprayed routinely in training exercises for decades, the foam soaked into soil and seeped into groundwater and drinking-water supplies — including systems serving military families. Firefighters were exposed at the nozzle; neighbors through contaminated water. That double exposure is why the litigation has a water-contamination track and a personal-injury track, with very different settlements.
The diseases plaintiffs link to AFFF exposure
Plaintiff cases concentrate on diseases with the strongest published PFAS links. Kidney cancer is repeatedly associated with PFOA in occupational studies and the landmark C8 Health Project. Testicular cancer is the other signature disease — several of the MDL's first bellwether trial candidates are testicular-cancer cases. Thyroid disease and thyroid cancer reflect PFAS links to thyroid disruption; ulcerative colitis carries a "probable link" finding from the C8 studies; liver cancer appears in the occupational literature. A diagnosis from this list does not alone qualify you — exposure history matters equally — but attorneys evaluate these diseases first.
Where the litigation stands in 2026
Federal cases were consolidated into MDL 2873 years ago. Water-provider claims — cities and utilities with contaminated systems — were largely resolved through the big settlements below. The live front in 2026 is the personal-injury track: firefighters and exposed residents seeking damages for their illnesses.
The court is running a bellwether program — representative cases prepared for trial so both sides see how juries respond. The first personal-injury bellwethers drawn from kidney- and testicular-cancer cases are the ones the entire plaintiffs' bar is watching, because their outcomes typically set the template for settlement negotiations. Defendants include 3M, DuPont and its spinoffs Chemours and Corteva, and other chemical and foam companies.
What 3M's $12.5 billion deal does — and doesn't — cover
The distinction matters: 3M's June 2023 agreement — later approved — pays up to $12.5 billion over 13 years to public water systems for PFAS contamination. DuPont, Chemours, and Corteva separately agreed to $1.185 billion for their own water-system claims. Neither deal compensates a single cancer patient — personal-injury claims were explicitly excluded and continue unaffected in the MDL. A qualifying diagnosis still opens a live, active track of this litigation.
Who can still file in 2026
Attorneys generally accept cases where three elements line up: exposure (firefighter, work at a base or facility where foam was used, or residence in a documented contamination area), diagnosis (a qualifying disease), and timing (filing within your state's deadline). Most states apply the discovery rule — the clock typically starts at diagnosis, not exposure — which keeps 2026 filings possible decades after service. Deadlines still vary by state, so a case review now beats waiting.
Related reading: New Jersey's $2.5 billion PFAS settlement; the turnout-gear PFAS lawsuit for equipment exposure; and the Paraquat lawsuit, another chemical-exposure MDL.
What filing looks like: cost and timeline
Nearly every AFFF plaintiff's firm works on contingency — nothing upfront, and the firm is paid only if your case recovers. A typical matter runs: free case review and medical-record gathering, filing of your complaint into the MDL, then discovery, then — for most plaintiffs — a negotiated settlement, since the overwhelming majority of mass-tort cases resolve without trial.
One honest note: compensation varies widely by case, and most individual settlements are confidential — no honest source can promise a number from a headline. What a strong filing gives you is a seat in the largest PFAS injury litigation in American history, documented by lawyers who handle only these cases. For visual explainers, see Problem Solved on YouTube. This is general information, not legal or financial advice — speak with a qualified attorney about your situation.
Who Benefits From This — and Who Does Not
This article is for firefighters, service members, and residents near contaminated sites who were later diagnosed with cancer — and who need to separate the water-system settlement headlines from their own personal-injury claim.
Who benefits:
- Firefighters and people who worked on military bases, airports, or refineries where AFFF was used: the foam was the standard suppressant at such facilities since the 1970s. How to use this article: check the three elements attorneys look for — exposure, a qualifying diagnosis, and timing under your state's discovery rule.
- People diagnosed with kidney cancer, testicular cancer, thyroid disease or thyroid cancer, ulcerative colitis, or liver cancer after PFAS exposure: these are the diseases attorneys evaluate first. How to use this article: pair your diagnosis with documented exposure history, since exposure without a qualifying disease generally does not support a claim.
- Readers confused by 3M's $12.5 billion deal: that agreement pays up to $12.5 billion over 13 years to public water systems — not to cancer patients. How to use this article: understand that personal-injury claims were explicitly excluded and continue separately in MDL 2873.
Who does not benefit:
- Water-system claimants expecting personal-injury money from the 3M deal: the $12.5 billion agreement — and DuPont, Chemours, and Corteva's separate $1.185 billion deal — compensate public water systems for contamination, not individual patients.
- Anyone with exposure but no qualifying disease: attorneys evaluate the listed diseases first, and exposure alone generally does not support a personal-injury claim.
- Anyone expecting a promised payout number: compensation varies widely by case and most settlements are confidential — no honest source can promise a number from a headline.
Read also: $2.5 billion PFAS settlement.
Frequently asked questions
Can I still file an AFFF lawsuit in 2026?
Yes, in many cases. Federal courts are still accepting new AFFF personal-injury filings into MDL 2873. You need documented exposure, a qualifying diagnosis, and filing within your state's deadline — under the discovery rule, that clock usually starts at diagnosis, so get a case review promptly.
What cancers qualify for an AFFF claim?
Attorneys evaluate kidney cancer, testicular cancer, thyroid disease and thyroid cancer, ulcerative colitis, and liver cancer first. Your lawyer reviews medical records and exposure history together — exposure without a qualifying disease generally does not support a claim.
Does 3M's $12.5 billion settlement cover cancer patients?
No. That settlement — up to $12.5 billion over 13 years — compensates public water systems for PFAS contamination, and DuPont, Chemours, and Corteva's separate $1.185 billion deal does the same. Personal-injury claims for disease were excluded and continue separately in the MDL.
How much does it cost to file an AFFF lawsuit?
Nothing upfront with a contingency-fee firm: the firm is paid only if your case recovers. As for what a case is worth — compensation varies widely by case and most settlements are confidential, so treat any specific number online as advertising, not a promise.
Who benefits most from this AFFF article?
Firefighters, service members, and residents near contaminated sites who were diagnosed with kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, or liver cancer after AFFF exposure — and anyone who needs to understand that 3M's $12.5 billion deal covers water systems, not cancer patients.
How do I start an AFFF claim review?
Document your exposure (firefighting service, work at a base or facility where foam was used, or residence in a documented contamination area) and your diagnosis, then seek a free case review promptly — most states apply the discovery rule, so the clock usually starts at diagnosis, and nearly every AFFF firm works on contingency with nothing upfront.
This article is general information, not legal or financial advice. Lawsuit deadlines and eligibility depend on your state and your facts — consult a qualified attorney for advice about your situation.